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Abstract: Canine reproductive physiology exhibits several unusual features. Among the most 
interesting of these are the lack of an acute luteolytic mechanism, coinciding with the apparent luteal 
independency of a uterine luteolysin in absence of pregnancy, contrasting with the acute prepartum 
luteolysis observed in pregnant animals. These features indicate the existence of mechanisms different 
from those in other species for regulating the extended luteal regression observed in non-pregnant 
dogs, and the actively regulated termination of luteal function observed prepartum as a prerequisite 
for parturition. Nevertheless, the supply of progesterone (P4) depends on corpora lutea (CL) as its 
primary source in both conditions, resulting in P4 levels that are similar in pregnant and non-pregnant 
bitches during almost the entire luteal life span prior to the prepartum luteolysis. Consequently, the 
duration of the prolonged luteal phase in non-pregnant bitches frequently exceeds that of pregnant 
ones, which is a peculiarity when compared with other domestic animal species. Both LH and prolactin 
(PRL) are endocrine luteotrophic factors in the dog, the latter being the predominant one. In spite of 
increased availability of these hormones, luteal regression/luteolysis still takes place. Recently, 
possible mechanisms regulating the expression and function of PRL receptor have been implicated in 
the local, i.e., intraluteal regulation of PRL bioavailability and thus its steroidogenic potential. Similar 
mechanisms may relate to the luteal LH receptor. Most recently, evidence has been provided for an 
autocrine/paracrine role of prostaglandin E2 (PGE2) as a luteotrophic factor in the canine CL acting at 
the level of steroidogenic acute regulatory (STAR)-protein mediated supply of steroidogenic substrate, 
without having a significant impact on the enzymatic activity of the respective steroidogenic enzymes, 
3β-hydroxysteroid-dehydrogenase (3βHSD, HSD3B2) and cytochrome P450 side-chain cleavage 
enzyme (P450scc, CYP11A1). Together with the strongly time-dependent expression of prostaglandin 
transporter, luteal prostaglandins seem to be involved more in the process of luteal formation than in 
termination of CL function in the dog. The possible roles of other factors such as vasoactive 
compounds, growth factors or cytokines have not been extensively studied but should not be 
neglected. 
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Abstract 6 
Canine reproductive physiology exhibits several unusual features. Among the most interesting 7 
of these are the lack of an acute luteolytic mechanism, coinciding with the apparent luteal 8 
independency of a uterine luteolysin in absence of pregnancy, contrasting with the acute 9 
prepartum luteolysis observed in pregnant animals. These features indicate the existence of 10 
mechanisms different from those in other species for regulating the extended luteal regression 11 
observed in non-pregnant dogs, and the actively regulated termination of luteal function 12 
observed prepartum as a prerequisite for parturition. Nevertheless, the supply of progesterone 13 
(P4) depends on corpora lutea (CL) as its primary source in both conditions, resulting in P4 14 
levels that are similar in pregnant and non-pregnant bitches during almost the entire luteal life 15 
span prior to the prepartum luteolysis. Consequently, the duration of the prolonged luteal 16 
phase in non-pregnant bitches frequently exceeds that of pregnant ones, which is a peculiarity 17 
when compared with other domestic animal species. Both LH and prolactin (PRL) are 18 
endocrine luteotrophic factors in the dog, the latter being the predominant one. In spite of 19 
increased availability of these hormones, luteal regression/luteolysis still takes place. 20 
Recently, possible mechanisms regulating the expression and function of PRL receptor have 21 
been implicated in the local, i.e., intraluteal regulation of PRL bioavailability and thus its 22 
steroidogenic potential. Similar mechanisms may relate to the luteal LH receptor. Most 23 
recently, evidence has been provided for an autocrine/paracrine role of prostaglandin E2 24 
(PGE2) as a luteotrophic factor in the canine CL acting at the level of steroidogenic acute 25 
regulatory (STAR)-protein mediated supply of steroidogenic substrate, without having a 26 
significant impact on the enzymatic activity of the respective steroidogenic enzymes, 3-27 
hydroxysteroid-dehydrogenase (3HSD, HSD3B2) and cytochrome P450 side-chain cleavage 28 
enzyme (P450scc, CYP11A1). Together with the strongly time-dependent expression of 29 
prostaglandin transporter, luteal prostaglandins seem to be involved more in the process of 30 
luteal formation than in termination of CL function in the dog. The possible roles of other 31 
factors such as vasoactive compounds, growth factors or cytokines have not been extensively 32 
studied but should not be neglected. 33 
 34 
1. Introduction 35 
As the primary source of progesterone (P4) during pregnancy and the non-pregnant cycle, 36 
corpora lutea seem to be key organs regulating the reproductive cycle in dogs. Hence, not 37 
surprisingly, the physiological mechanisms regulating CL function have been subjected to 38 
increased scientific interest. However, even though expression and/or function of several, 39 
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 3 
mostly luteotrophic, factors have been characterized, overall understanding of canine CL 40 
physiology remains poor, especially during its regression. Dogs are highly important in 41 
veterinary medicine, have a substantial role as laboratory animals and are also among the 42 
most important pets. Taking all of this into account, efforts need to be made to better 43 
understand canine reproductive physiology, especially that concerning CL function.  44 
In addition to the lately debate (e.g., [1-6]), here an overview of our current knowledge 45 
concerning the endocrine, paracrine and autocrine control of the CL in non-pregnant and 46 
pregnant dogs, together with some new, unpublished data recently generated in our 47 
laboratory, e.g., concerning the expression of 15-hydroxy prostaglandin dehydrogenase 48 
(HPGD) and the LH receptor (LHR), is presented. 49 
 50 
2. Luteal life span and patterns of steroid secretion 51 
Among domestic animal species, the domestic dog (Canis lupus familiaris) is the only one 52 
classified as a predominantly non-seasonal, monoestrus breeder. The sexual cycle is 53 
characterized by a long luteal phase (diestrus) and an obligatory sexual quiescence phase 54 
between sexually active periods (anestrus), the length of which may depend on the breed [7]. 55 
Unlike in livestock, in which cyclicity depends on periodic production and secretion of 56 
luteolytic prostaglandin F2 (PGF2) by the uterus, at least in non pregnant dogs the luteal 57 
function is independent of a uterine luteolysin, because ovarian cyclicity is maintained 58 
following hysterectomy [8]. Consequently, also pointing towards inherent control 59 
mechanisms, the physiological luteal lifespan is similar in pregnant and non-pregnant bitches.  60 
 61 
2.1. Progesterone 62 
Following preovulatory luteinization, peripheral progesterone (P4) reaches levels of about 5 63 
ng/ml at the time of ovulation [9]. After ovulation, strongly increasing luteal steroidogenic 64 
capacity results in the highest circulating P4 levels 15-25 days, or even up to 30 days after 65 
ovulation [8]. Then, a progressive P4 decrease marks the onset of luteal regression, which 66 
lasts in non-pregnant dogs as long as 1-3 months, until peripheral P4 levels falling below 1 67 
ng/ml, by definition, indicate the onset of anestrus [9]. The P4 secretion pattern, which is up 68 
to that time-point similar in the non-pregnant and pregnant bitch, starts to differ at 69 
approximately day 60 of the luteal lifespan, when the circulating P4 concentration falls 70 
precipitously in the pregnant animal as a prerequisite for parturition (prepartum luteolysis), 71 
therefore rapidly reaching baseline levels.  72 
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While individual serum P4 levels vary strongly, the mean values can measurably differ 73 
between pregnant and non-pregnant bitches during the entire course of diestrus displaying 74 
values that are numerically but not statistically lower in the non-pregnant animals. In one 75 
study by Steinetz et al. [10], the mean P4 concentrations in pseudopregnant bitches were only 76 
56% of the concentrations in pregnant females. Nevertheless, mostly due to the above-77 
mentioned high individual variations, measurement of serum P4 is precluded as a means to 78 
distinguish between pregnant and non-pregnant dogs.  79 
 80 
2.2. Estrogens 81 
Because the canine placenta is devoid of steroidogenic activity [11,12], circulating estrogens 82 
appear to originate in corpora lutea (CL). This notion has been supported by studying the 83 
time-dependent  expression of aromatase in canine luteal samples throughout diestrus [1,12]. 84 
There is, however, no pregnancy-associated increase in estradiol-17 (E2) production, and 85 
similar E2 secretion patterns are observed in both pregnancy and diestrus of non-pregnant 86 
dogs until the prepartum drop is observed, as for P4 [11,13]. This prepartum drop in E2 87 
further implicates CL as the major source of estrogens in the dog.  88 
Both E2 and P4 exert autocrine and/or paracrine, presumably luteotrophic, effects on the 89 
canine CL, since their respective receptors, i.e., P4 receptor (PGR) and estrogen receptors -90 
alpha and -beta (ER and ER), are expressed locally. This concept is further supported by 91 
the observation that interfering with P4 action at the level of PGR, e.g., by application of an 92 
antigestagen, results in preterm luteolysis [14,15]. It is possible that, indirectly, estrogens 93 
could act by priming PGR and prolactin receptor (PRLR) expression.  94 
 95 
2.3. Cortisol 96 
The elevated levels of cortisol measured in maternal blood peripartum appear to have erratic 97 
nature and seem to be not mandatory for normal parturition [16]. It has also been related to 98 
maternal stress [11, 16]. On the other hand, as suggested by Concannon and collaborators 99 
[16], it is possible that cortisol circulating in maternal blood prepartum merely reflects much 100 
larger increases at the feto-placental and uterine levels.  101 
 102 
3. Luteal development, morphological and functional characteristics 103 
As in other species, the formation of the canine CL starts from residual follicular cells right 104 
after ovulation. Early luteal development is characterized by strong proliferation of all cellular 105 
components, as indicated by increased expression of the Ki67 marker in lutein and non-lutein 106 
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 5 
cells [1]. At the same time the significantly increased staining of endoglin, points towards a 107 
high vascularization rate during the early luteal phase, especially on day 15 after ovulation 108 
[17], after which it is considerably lower. The strong vasculogenic and angiogenic activities 109 
are also evidenced by the expression of members of the vascular endothelial growth factor 110 
(VEGF) system in steroidogenic and non-steroidogenic cells [18].  111 
Unlike in livestock, in which lutein cells can be divided into small- (theca interna- 112 
derived), and large- (granulosa cell-derived) lutein cells, no such distinction can be made in 113 
dogs. Although, as in other species, likewise, canine lutein cells develop from both of these 114 
cell populations, only one type of steroidogenic cell can be identified in dogs both 115 
histomorphologically and ultrastructurally [19] (Fig 1). The extent to which granulosa and 116 
theca cells contribute to CL formation is not known. However, the strong preovulatory 117 
luteinization observed in maturing canine follicles suggests an important role of granulosa 118 
cells in this process. 119 
In the growing canine CL, the lutein cells are irregularly shaped, with a diameter at day 5 120 
after ovulation of 5-10 μm, exhibiting large, bright nuclei containing one or two nucleoli and 121 
cytoplasm filled with small lipid droplets [19]. While extravasated erythrocytes can still be 122 
observed in luteal tissue, e.g., at days 5-10 after ovulation, indicating the haemorrhagic stage 123 
of development (Fig. 1A,B), already at this stage of luteal development intense 124 
vascularization is evident as a well-established capillary network. At day 15 after ovulation, 125 
lutein cells are approximately 20 μm in size, while the diameter of fully developed lutein cells 126 
at days 20-25 after ovulation is around 30-40 μm. They are polyhedral, tightly packed, with 127 
homogeneous nuclei, fewer lipid droplets than during the growth phase, but with large 128 
number of mitochondria and smooth endoplasmatic reticulum (Fig. 1C,D). At this time, in the 129 
mature CL, proliferative activity is already reduced [1] and the luteal vascular bed is fully 130 
established (Fig. 1C,D) providing virtually all lutein cells contact with a capillary [17]. The 131 
latter is a phenomenon known from other species, allowing for maximal supply of P4 from 132 
the CL to target organs, e.g., the utero/placental compartment. It is conceivable that the 133 
function of the freshly formed capillaries as well as of the lutein cells is modulated by a set of 134 
vasoactive factors that are as yet not fully defined in the dog.  135 
The strong proliferative activity observed during early development of the CL is followed 136 
by continuously increasing steroidogenic activity, which in turn is reflected in the highly 137 
upregulated expression of steroidogenic acute regulatory protein (STAR) and 3-138 
hydroxysteroid-dehydrogenase (3HSD, HSD3B2), the two key factors involved in the 139 
precise control of hormonal output from most of the steroidogenic tissues. STAR is 140 
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 6 
responsible for the active transport of cholesterol from the outer to the inner mitochondrial 141 
membrane and, hence, for the supply of steroidogenic substrate, whereas 3HSD controls the 142 
last step of P4 synthesis, namely the conversion of pregnenolone to P4. The expression 143 
patterns of both factors throughout diestrus closely parallel the peripheral P4 content in 144 
pregnant and non-pregnant dogs [14,20,21]. Taking this into account, as well as the 145 
potentially superior role that STAR plays compared to 3HSD (being responsible for the 146 
substrate supply for the subsequent enzymatic reaction), STAR-dependent mechanisms seem 147 
to play a rate-limiting role within the canine CL controlling luteal enzymatic conversion rate 148 
and, thus, steroidogenic capacity. This is further supported by a recent study from our group 149 
in which STAR, but not 3HSD and cytochrome P450 side-chain cleavage enzyme (P450scc, 150 
CYP11A1; factor responsible for enzymatic cleavage of cholesterol to pregnenolone), was 151 
significantly affected in prostaglandin E2 (PGE2)-treated canine luteal cells isolated from 152 
early CL. This treatment resulted in increased STAR mRNA and protein expression and its 153 
functional activation, i.e., phosphorylation, as evidenced from up-regulated [2] 154 
steroidogenesis, which was similar to levels obtained with cAMP.  155 
The cAMP/PKA pathway, involving activation of many transcriptional factors serving 156 
both in the basal and induced STAR-promoter activity, is indisputably the major pathway in 157 
the trophic-hormone dependent expression and activation of STAR. Recently, canine 158 
proximal -255/-1 promoter was cloned and compared with its well-characterized murine 159 
counterpart, revealing several putative binding sites for transcriptional factors, e.g., CCAAT-160 
enhancer-binding protein (C/EBP), steroidogenic factor (SF)1/2, SF1/3, GATA, sterol 161 
regulatory element-binding protein (SREBP) or DAX1 (dosage-sensitive sex reversal, adrenal 162 
hypoplasia critical region, on chromosome X, gene 1) [2]. Additionally, two cAMP-163 
responsive element half-sites (CRE-half-sites) corresponding to murine CRE-1 and CRE-3, 164 
were found [2]. Finally, the functional responsiveness of canine STAR-promoter to cAMP 165 
was confirmed [2]. More detailed studies should be considered to elucidate the identity of the 166 
upstream regulating factors, as well as the relative importance of the specific transcriptional 167 
factors in STAR-mediated luteal progesterone synthesis in dogs.  168 
As the CL enters the mid-luteal phase, STAR expression decreases [14,20] resulting in 169 
declining peripheral P4 levels; i.e., the luteal regression sets in. By day 30 after ovulation, the 170 
endoplasmic reticulum exhibits whirl-like structures and is localized mostly in the periphery 171 
of lutein cells, not close to the nucleus. Clear signs of structural regression become visible at 172 
day 45 after ovulation (Fig. 1E,F): intercellular distances become larger, the density of 173 
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 7 
capillaries decreases, the numbers of collagen fibres and cellular components of connective 174 
tissue increase, and larger lipid droplets start to be visible all over the cytoplasm of lutein 175 
cells, indicating ongoing fatty degeneration. The whirl-like smooth endoplasmic reticulum of 176 
steroidogenic cells encircles now large lipid droplets as a further sign of fatty degeneration 177 
[19], likely additionally contributing to diminished steroid production. Marked signs of 178 
degeneration can be seen approximately 20 days later (Fig. 1G,H). Lutein cells become 179 
irregular in shape and size, and chromatin condensation commences; somewhat later, nuclei 180 
become noticeably pyknotic, large lipid vacuoles are observed in the cytoplasm, the number 181 
of mitochondria decreases significantly, and the amount of connective tissue elements and 182 
collagen fibres increases significantly [19].  183 
It is noteworthy that the above-described progressive luteal regression takes place absent 184 
of any active luteolytic principle, e.g., strong apoptotic signals, that would be observed in the 185 
CL of non-pregnant dogs, making apoptosis the major mechanism regulating functional luteal 186 
regression [6,19] in this species. Caspase-3 seems to be involved here in functional and 187 
structural regression and in the tissue reorganization associated with corpus albicans 188 
formation [22]. This is in contrast to pregnant dogs in which the steep P4 decline during 189 
prepartum luteolysis, coinciding with significantly increased levels of PGF2 in maternal 190 
peripheral blood, is associated with strong apoptotic signals, as evidenced by 191 
immunohistochemical staining for active caspase-3 (Fig. 2). This needs to be seen as 192 
indicative of different regulatory mechanisms involved in termination of CL function in 193 
pregnant vs. non-pregnant dogs, pointing towards an actively regulated process of CL 194 
destruction at the end of gestation. The immunohistochemical results presented in Fig. 2 were 195 
obtained according to our previously published protocol [21,23]. The primary antibody was 196 
rabbit anti-active caspase-3 IgG (BD Biosciences) at a dilution of 1:50; as a negative/isotype 197 
control, IgG irrelevant antibodies I-5000 (Vector Laboratories Inc., Burlingame, CA, USA) 198 
were used at the same concentration as the primary antibody; the secondary antibody was 199 
biotinylated goat anti-rabbit IgG BA-1000 from Vector Laboratories. 200 
 201 
4. Immune system 202 
Even though still not fully elaborated, there is evidence for potential involvement of the 203 
immune system in the regulation of canine luteal function. Thus, not surprisingly, the 204 
presence of CD4- and CD8- positive immune cells, as well as the expression of the major 205 
histocompatibility complex class II (MHC II)-complex, was confirmed in canine CL 206 
throughout the luteal life span of non-pregnant dogs. The cluster of differentiation (CD)4- 207 
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 8 
positive cells were identified as lymphocytes and macrophages, the CD8- positive cells were 208 
T-lymphocytes. The MHC II-complex stained for T-lymphocytes and macrophages and also 209 
for fibroblasts and some of the lutein cells [6,17]. Strong vascularization and early luteal 210 
development were characterized by increased presence of T-lymphocytes and macrophages. 211 
A renewed increase in CD8- and MHC II- positive immune cells was noticed late during 212 
luteal regression (at days 45- and 60 after ovulation, respectively), implying that, as in other 213 
species, in the dog, immune cells together with cytokines produced by them may be involved 214 
in regulatory processes at both ends of the luteal life span, i.e., at luteal formation and 215 
regression [6,17].  216 
Only sparse information is available concerning luteal cytokines in the dog. The 217 
expression of interleukin (IL)-8, IL-10, IL-12, tumor necrosis factor (TNF) and transforming 218 
growth factor beta 1 (TGF1), but not of IL1, IL-2 and IL-4, could be detected qualitatively 219 
at the mRNA level [24]. The expression of IL-6 and interferon (IFN)γ was erratic and 220 
frequently below the detection limit [24]. Recently, in our ongoing project, the luteal 221 
expression of TNF and its two receptors (TNFR-1 and -2) was confirmed at the protein level 222 
throughout diestrus (own data, unpublished). Cumulatively, it may be reasonably assumed 223 
that immune system-derived cells and their products play an important or at least a 224 
modulatory role during the course of canine diestrus, with a functional shift between the 225 
beginning and the end of the CL phase. The involvement and role of individual factors 226 
remain, however, to be elucidated.  227 
 228 
5. Gonadotrophic regulation  229 
5.1. Secretion patterns of prolactin (PRL) and luteinizing hormone (LH)  230 
After observing relatively low levels of serum PRL at the beginning of pregnancy, a 231 
substantial increase can be measured during the second half of gestation; after approximately 232 
5-6 weeks, PRL levels start to increase steadily towards parturition [25-27], peaking at about 233 
50 ng/ml near term [25]. In non-pregnant bitches, basal PRL remains low during most of the 234 
luteal phase, and increase 2-3 fold from the initial levels of 2-4 ng/ml, reaching maximum 235 
levels of about 9 ng/ml around the time corresponding to parturition in pregnant bitches 236 
[25,26]. High plasma PRL concentrations can also be measured in overtly pseudopregnant 237 
bitches, therefore, increased levels of PRL are not reliable indicators for detection of 238 
pregnancy [28]. The pregnancy-associated increase in PRL is concomitant with placental 239 
relaxin secretion that begins between days 25 and 30 and persists until term [29], suggesting a 240 
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 9 
stimulatory role of relaxin on PRL secretion, and possibly explaining higher P4 levels 241 
observed during pregnancy. Such a regulatory mechanism would resemble the modulatory 242 
role of relaxin on PRL secretion that was previously demonstrated in pigs and monkeys 243 
[30,31]. Within the canine placenta, the syncytiotrophoblast has been identified as the 244 
possible source of relaxin [32].  245 
Similar to PRL, the concentrations of LH also appear to increase during the progression 246 
of diestrus. Thus, increased circulating LH has been observed while P4 concentrations 247 
continue to decrease, indicating that the cessation of luteal function does not result from a 248 
lack of either LH or PRL [33,34].  249 
 250 
5.2. Effects of hypohysectomy 251 
Whereas, indisputably, both PRL and LH are luteotrophic hormones in the dog, the extent to 252 
which pituitary support is required for luteal maintenance, as well as its exact timing, awaken 253 
some controversies and are the subjects of continuous debate in canine literature (see, e.g., 254 
[35-38]). Thus, during the first 2-4 weeks of luteal development, dynamically growing canine 255 
CL, producing increasing levels of P4, reveal a reduced sensitivity to luteolytic insults that are 256 
clearly effective later in diestrus. In this regard, as shown by Okkens and collaborators [39], 257 
hypophysectomy, and hence deprivation of gonadotrophic support, at day 4 after ovulation 258 
resulted only in a transient suppression in circulating P4 levels, which recovered to normal 259 
values within 6-10 days. This was, however, not the case for dogs hypophysectomized on day 260 
18 of the luteal phase, whose P4 decline was permanent [39]. The initial acute P4 decrease 261 
observed after hypophysectomy performed at day 4 after ovulation was interpreted as a 262 
consequence of surgical stress, as indicated also elsewhere [40,41]. Interestingly, the luteal 263 
life span was significantly shortened in dogs in which P4 levels recovered, compared with 264 
controls. This can be seen as an indicative of the luteotrophic function of pituitary hormones 265 
predominantly during the later luteal stages. On the other hand, in studies performed by 266 
Concannon et al. [35], hypophysectomies performed on days 10-50 of the cycle resulted in 267 
permanent P4 suppression within 3-17 days.  268 
Cumulatively, there is evidence indicating that the canine CL is to some extent 269 
autonomous, at least during its earliest developmental stages. Based on their investigations 270 
Okkens et al. [39] speculated that this period ends at days 24-28 of the CL life span. However, 271 
Concannon [35] postulated the canine CL to be chronically dependent on gonadotrophic 272 
support throughout the luteal phase. There is only low PRL gene expression in the canine CL 273 
and uterus throughout diestrus mostly below the detection limit. Therefore, even if a possible 274 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 10 
auto/paracrine function of intraluteally secreted PRL cannot be ruled out, these do not seem to 275 
contribute significantly to the circulating PRL (own data, unpublished).  276 
 277 
5.3. Luteotrophic function of PRL and LH 278 
Whereas during the second half of its life span the canine CL depends upon gonadotrophic 279 
support, the deprivation of which unequivocally results in cessation of luteal function, some 280 
refractoriness can be observed during earlier luteal stages. Thus, suppression of PRL secretion 281 
by the dopamine agonist bromocriptine used over six days starting on days 8 and 22 of 282 
pregnancy resulted in only a temporal P4 decline during the treatment. This was followed by a 283 
2-6 day recovery phase after which P4 concentrations returned to normal values and all dogs 284 
gave birth to normal litters [36]. In contrast, in the same study, in dogs treated on day 42 of 285 
pregnancy and on the corresponding day 42 of the non-pregnant cycle, P4 concentrations 286 
decreased below 2 ng/ml, which is a value necessary to maintain pregnancy, CL function was 287 
terminated and all pregnant bitches aborted [36]. This is consistent with findings reported by 288 
Onclin et al. [42], i.e., bromocriptine decreased P4 levels below 2 ng/ml in all dogs when 289 
applied 40 days after first mating and in approximately 66% dogs (four out of six dogs used in 290 
that study) when applied 30 days after mating. This, together with the above-cited shortening 291 
of the CL-phase in dogs hypophysectomized on day 4 of the luteal life span, can be seen as 292 
indicative of the time-dependent increase in sensitivity of the canine CL towards PRL during 293 
progression of the luteal phase. The negative effects of bromocriptine on P4 secretion could 294 
be reversed by treatment with PRL but not with LH [43], indicating an indirect effect of 295 
bromocriptine on luteal function but also suggesting a superior role of PRL in maintenance of 296 
canine CL function compared with LH. This is also consistent with the observation that 297 
blocking LH function at the time of full PRL-dependency of the CL resulted in only a 298 
transient P4 decrease [36], even though LH was capable of stimulating P4 production in vivo 299 
[35]. The latter finding is, however, in contrast with observations by Onclin and Verstegen 300 
[38] who reported unchanged P4 concentrations after LH application. Consequently, for the 301 
mature canine CL, i.e., during the second half of diestrus, PRL becomes the main luteotrophic 302 
hormone [36-38]. This is also in contrast to other domestic animal species in which CL 303 
function strongly depends on provision of LH, e.g., pigs [44], horses [45] or cattle [46]. 304 
Moreover, besides its probable direct effect on lutein cells, LH seems to be capable of 305 
stimulating PRL secretion as shown in one study [38], indicating a possible indirect role of 306 
LH as a mediator in PRL-dependent P4 synthesis. On the other hand, PRL did not stimulate 307 
LH production and suppression of PRL secretion did not affect LH levels [43]. There was also 308 
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no direct stimulatory effect of PRL on plasma P4 [43]. Consequently, although PRL appears 309 
to be the essential luteotrophic factor from the mid-luteal phase onwards, both during 310 
pregnancy and in the non-pregnant canine cycle, its role was suggested in sustaining CL 311 
function and/or slowing down luteal regression, rather than in active stimulation of P4 312 
production [43]. 313 
 314 
5.4. Expression of prolactin- and luteinizing hormone-receptors (PRLR and LHR) 315 
Recently, the partial sequence of canine PRLR cDNA corresponding to the portions of the 316 
extra- and trans-membrane domains conserved within the PRLR isoforms of other species 317 
was cloned and sequenced in our laboratory [23]. Making use of its availability, the 318 
expression of PRLR was investigated in canine CL from non-pregnant and pregnant animals, 319 
revealing a time-dependent expression pattern with highest messenger and also protein levels 320 
observed at the beginning of the CL phase, and significantly decreased levels towards the end 321 
of the luteal life span and/or luteolysis [23]. This cycle-stage related expression of PRLR 322 
implies a possible functional interrelationship with respect to circulating P4 levels and 323 
suggests that PRLR could act as an upstream regulator in luteal steroid generation in the dog, 324 
e.g., at the level of STAR and/or 3HSD, since their expression patterns resemble that of 325 
PRLR. Further studies aimed at delineating complete cDNA of dog-specific PRLR and its 326 
potential isoforms are ongoing. 327 
As for the LHR, its expression has not been investigated to date at the molecular level in 328 
canine CL. The only contribution is by Fernandes et al. [47] who reported on LHR-binding 329 
sites in luteal samples throughout diestrus of non pregnant dogs, which did not change 330 
significantly over time. Here, as presented in Fig. 3, the expression of LHR was investigated 331 
in luteal samples collected from non-pregnant dogs during the course of diestrus (days 5, 15, 332 
25, 35, 45 and 65 after ovulation; n=5-6 per group), as well as from pregnant dogs during the 333 
pre-implantation period (days 8-12, n=5, determined by embryo flushing), post-implantation 334 
(days18-25, n=5), midgestation (days 35-40, n=5) and at prepartum luteolysis (n=3). The day 335 
of ovulation was determined by monitoring P4 content in peripheral blood, and was defined 336 
as the day when P4 levels reached values of 5 ng/ml [9]. For pregnant dogs, the day of mating 337 
was recorded (day 0). Prepartum luteolysis was controlled by determining P4 levels every 6 338 
hr beginning with day 58 of pregnancy; when P4 levels continued to decrease below 3 ng/ml 339 
within two consecutive measurements, ovario-hysterectomy was performed. More detailed 340 
descriptions of the experimental procedure can be found in [14,15,23].  341 
The luteal expression of LHR was investigated at the mRNA level using the in GenBank 342 
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available canine-specific partial cDNA sequence. Its expression was strongly time-related 343 
(P<0.01) in both pregnant and non-pregnant bitches (Fig. 3). In the non-pregnant dogs, the 344 
formation of CL was associated with increasing LHR expression, which was significantly 345 
(P<0.001) upregulated at days 15 and 25 after ovulation. The decrease observed thereafter, 346 
towards day 35, was significant (P<0.05) compared with the highest expression at day 15. The 347 
apparently increased expression on days 45 and 65 was not significant (P>0.05). A less 348 
dramatic expression pattern was observed for LHR during pregnancy. Its expression increased 349 
continuously towards mid-gestation (p<0.05), and the apparent decrease during prepartum 350 
luteolysis was not significant (P>0.05). 351 
The diminished expression of PRLR and LHR in CL of non-pregnant dogs coincides with 352 
the onset of luteal regression. Whether this is a trigger or a result of the slowly ongoing 353 
degeneration process, leading to reduced P4 synthesis, remains to be elucidated. Together, 354 
however, with the observation that PRL did not stimulate P4 synthesis directly, but seemed 355 
rather to be involved in sustaining CL function [43], this finding suggests that the PRLR-356 
mediated decline in luteal responsivity to gonadotrophic support could be one of the possible 357 
triggers leading to termination of canine CL function. This could also provide an explanation 358 
of one of the most intriguing peculiarities of canine reproduction, which is the fact that even if 359 
gonadotrophins are needed for proper luteal maintenance, luteal regression/luteolysis take 360 
place in spite of continuously increasing availability of PRL and LH, because the function of 361 
the degenerating CL cannot be rescued by luteotrophic stimulation.  362 
Even though, based on the above-discussed evidence, the role of LH in regulating CL 363 
function in dogs seems to be secondary to that of PRL, the meaning of the deviating 364 
expression profile of LHR in the CL of pregnancy merits further investigation, possibly 365 
involving more frequent tissue sampling allowing for more thorough temporal analysis of 366 
gene expression.  367 
For all semi-quantitative real time (TaqMan) PCR analyses presented herein, our 368 
previously described protocols [21,23,48] were applied. Samples were always run in duplicate 369 
with three reference genes: GAPDH, 18RrRNA and cyclophilin A, used for normalization of 370 
target gene expression in the comparative ΔΔCT method. The so-called „RT minus‟ controls 371 
(samples that were not reverse-transcribed) and „no-template‟ controls were included in every 372 
experiment. Reactions were set to achieve approximately 100% efficiency. Primers and 373 
FAM/TAMRA-labelled TaqMan Probes sequences are listed in Table 1. 374 
 375 
6. Intraluteal prostaglandins 376 
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Luteal growth involves the upregulated expression of cyclooxygenase 2 (COX2, PTGS2), the 377 
rate-limiting factor in the synthesis of prostaglandins (PGs) [14,49]. Its expression correlates 378 
positively with the expression of PGE2-synthase (PGES) [14,50] (a downstream enzyme 379 
responsible for the conversion of PTGS2-derived PGH2 to PGE2), as well as with the 380 
expression of prostaglandin transporter (PGT). The initially elevated expression of both 381 
enzymes decreases significantly during luteal regression, as does the expression of PGT, 382 
indicating the role of intraluteally produced PGs during the formation but not the regression 383 
of the canine CL [2,14,49,50].  384 
Aiming to delineate possible autocrine and paracrine regulatory mechanisms, recently 385 
compelling functional evidence has been provided by our group for the luteotrophic function 386 
of PGE2 within the canine CL. Prostaglandin E2 proved to be an activator of steroidogenesis 387 
in primary luteal cell cultures isolated from the early luteal stage, acting at the level of STAR 388 
protein without having a significant impact on the 3HSD and P450scc enzymatic activity 389 
[2]. Expression of the two cAMP-pathway-linked PGE2 receptors, EP2 and EP4 was clearly 390 
detectable at the protein level in CL isolated from pregnant dogs. These receptors were 391 
localized in lutein cells and revealed CL-stage dependent expression patterns. Whereas the 392 
expression of EP2 decreased towards prepartum luteolysis, EP4 expression was biphasic and 393 
peaked twice, during the early luteal phase and, unexpectedly, also at mid-gestation [2]. The 394 
potential functional importance of these findings, as well as the relative functional 395 
involvement of both receptors in luteal maintenance, merits further study, also in context of 396 
the possible interplay between PGE2 and other luteotrophic factors, e.g., PRL or LH.  397 
Based on the already mentioned fact that in the dog luteal function is not affected by 398 
hysterectomy, a hypothesis was put forward that PGF2 could act locally and intraluteally as 399 
a luteolytic factor in the diestrous bitch. Consequently, the luteal expression of PGF2-400 
synthase (PGFS), classified as AKR1C3, was investigated throughout diestrus [14,51]. 401 
AKR1C3 is the only known canine-specific PGFS isoform isolated to date [51] and is 402 
responsible for the enzymatic conversion of PGH2 to PGF2 [52,53]. As determined at the 403 
mRNA-level, its expression was either absent or very weak, frequently below the detection 404 
limit, in the CL of non-pregnant bitches [51]. Together with the low PGF2-metabolite 405 
(13,14-dihydro-15-keto-PGF2; PGFM) levels observed in peripheral blood during luteal 406 
regression [54], this further points towards the lack of an endogenous luteolysin in non-407 
pregnant dogs. Most recently, applying a canine-specific custom-made antibody, PGFS 408 
(AKR1C3) expression was assessed at the protein level in the CL of pregnancy revealing 409 
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barely detectable signals [52,53]. Interestingly, the PGF2-receptor seems to be constitutively 410 
expressed in the canine CL. It is localized solely in the lutein cells and its mRNA level 411 
increases with the progression of the luteal phase, although it is less pronounced during 412 
pregnancy [14,51]. The latter might explain the shift in luteal receptivity to exogenously 413 
administered PGF2 later in diestrus.  414 
Due to chemical instability and catabolic inactivation, PGs exhibit a very short half-life in 415 
vivo. The first step in their enzymatic deactivation is the 15-hydroxy prostaglandin 416 
dehydrogenase (HPGD)-mediated oxidation of the 15-hydroxyl group to a 15-keto group 417 
[55,56]. This process generates the biologically inactive metabolites of PGE2 and PGF2, 418 
PGFM and 13,14-dihydro-15-keto PGE2 (PGEM). Consequently, HPGD is the key enzyme 419 
regulating the biological availability of prostaglandins. Making use of the recently cloned 420 
canine-specific HPGD cDNA sequence [52,53], its luteal expression was investigated 421 
throughout pregnancy and at prepartum luteolysis, revealing strongly individually varying 422 
values that tended to be higher at earlier luteal stages and decreasing towards parturition [52].  423 
Here, the luteal expression of HPGD was determined in canine CL obtained from non-424 
pregnant bitches hysterectomized between days 5-65 after ovulation (the same samples as for 425 
determining LHR expression) (Fig. 4). For primers and FAM/TAMRA-labelled TaqMan 426 
Probe sequences see in Table 1. There was a significant effect of time for luteal HPGD 427 
expression in non-pregnant dogs (P<0.01, Fig. 4); it was lowest at day 5 after ovulation, then 428 
increased significantly, peaking at day 15 (P<0.01), with no further significant changes 429 
observed during the slow process of luteal regression. The expression pattern of HPGD 430 
presented in Fig. 4 seems to be negatively correlated with the previously reported PGES and 431 
PGT expression [2,50], implying its role as a factor involved in the local supply of 432 
luteotrophic PGE2. 433 
 434 
7. Prepartum Luteolysis  435 
Keeping in mind the abrupt P4 decline and the associated massive apoptotic signals detected 436 
in the CL during prepartum luteolysis (Fig. 2), occurring concomitantly with strongly elevated 437 
PGF2 output, it seems obvious that the prepartum luteolysis is an actively regulated process. 438 
Another apparent sign of luteolysis is the significant drop in luteal STAR expression [2,14].  439 
As the vascularization of the CL was already slowed down by the mid-luteal phase and 440 
did not change significantly later on, Hoffmann et al. [6,17] postulated that changes in the 441 
vascular supply are probably less important as contributors to luteal regression/luteolysis than 442 
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in other species. Indeed, in accordance with this hypothesis, in the present experiments (Fig. 443 
5A-C), the mRNA expression of VEGF164 and the two VEGF receptors, VEGFR1 (Flt1) and 444 
VEGFR2 (KDR/Flk1), did not differ significantly (P>0.05) between luteal samples obtained 445 
from mid-pregnant dogs (days 35-40 of pregnancy; n=5) vs. those collected during prepartum 446 
luteolysis (n=3) (Fig. 5A-C). On the other hand, however, in our ongoing study, prepartum 447 
luteolysis was associated with significantly increased expression of endothelin receptor type 448 
A (EDNRA; ETA), a vasoactive factor known for its strong vasoconstrictor properties. At the 449 
cellular level ETA was localized in luteal capillary endothelial cells. No such increase was 450 
observed during luteal regression in non-pregnant dogs (own data, unpublished). The 451 
functional implication of these findings and their role in the luteolytic cascade remain to be 452 
elucidated. In the present experiments, the expression of VEGF system was assessed using 453 
primers and TaqMan Probes listed in Table 1.  454 
Because the canine PGFS (AKR1C3) was cloned for the first time using mRNA isolated 455 
from the uteroplacental compartment [51], we felt prompted to investigate the capacity of 456 
these tissues to produce prostaglandins, with respect to prepartum luteolysis. Consequently, it 457 
was concluded that the prepartum increase in luteolytic PGF2 may originate in the 458 
upregulated expression of PTGS2 (COX2) within the uteroplacental unit, more specifically, in 459 
the placenta fetalis, where the upregulated PTGS2 is co-localized with PGFS (AKR1C3) [15]. 460 
Our findings agree with the conclusion of Luz et al. [54,57] who postulated the placenta as the 461 
main source of the luteolytic PGF2 increase. The underlying alterations in the feto-maternal 462 
communication between the maternal stroma-derived decidual cells, the only cells expressing 463 
PGR in the canine placenta, and the fetal trophoblast cells, seem to possess a triggering 464 
function in the subsequent luteolytic endocrine cascade [15].  465 
 466 
8. Antigestagens 467 
As demonstrated in experiments utilizing an antigestagen (aglepristone) in mid-pregnant 468 
dogs, interfering with P4 function and/or activity at the level of its receptor initiates an 469 
endocrine cascade closely resembling that observed during normal luteolysis. Thus, the 470 
uteroplacental prostaglandin system becomes activated, resulting in increased uteroplacental 471 
PGF2 output and leading to preterm luteolysis and/or abortion [15,58]. At the CL level, 472 
significant downregulation of STAR and 3HSD is observed and is mirrored in dropping 473 
peripheral P4 levels [14]. Similar to normal luteolysis, at least initially at the beginning of the 474 
response to antigestagen treatment, the morphological alterations do not involve vascular 475 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 16 
changes, as shown by the initially unaltered luteal expression of the VEGF system within the 476 
first 24 hrs after the antigestagen treatment (Fig. 5A-C). Functionally, as found in our ongoing 477 
study, expression of the vasoconstrictor endothelin receptor A is strongly elevated (own data, 478 
unpublished). 479 
 480 
9. Conclusions 481 
Amongst the domestic animal species, the dog is the only one with a luteal phase whose 482 
duration in non-pregnant animals exceeds that observed during pregnancy. This is not only 483 
unique, but also implies distinctly different mechanisms regulating the function of corpora 484 
lutea in both situations. In non-pregnant animals, being independent of any uterine luteolysin, 485 
the CL fully completes its inherent life span, slowly undergoing morphological and functional 486 
changes that, devoid of an active luteolytic principle, appear to be mostly related to the ageing 487 
of the CL. This is evidenced by the progressive fatty degeneration of luteal structures. In 488 
contrast, in pregnant animals, the initially slow luteal regression seems to be interrupted by 489 
the suddenly occurring prepartum luteolysis, associated with strongly increasing peripheral 490 
levels of (mostly placenta-derived) PGF2 targeting the constitutively-expressed luteal 491 
PGF2 receptor and, thereby, actively destroying the CL (Fig 6). 492 
Several factors seem to regulate luteal function in the dog, presenting an apparent 493 
functional shift during different stages of luteal development: whereas prostaglandins seem to 494 
be involved rather in CL formation, gonadotrophic support seems to be more important for 495 
luteal maintenance (Fig. 7). The modulatory role of many other biologically active factors, 496 
e.g., those related to energy balance or glucose uptake, such as insulin receptors and glucose 497 
transporters, is implicated and is currently under discussion and/or investigation.  498 
Nevertheless, mechanisms governing canine CL function are still far from being well 499 
understood. The impaired response to trophic stimulation of canine luteal cells isolated from 500 
later luteal stages [2,19] indicates the presence of other, not yet defined, endocrine and/or 501 
paracrine regulatory mechanisms, making the canine CL an experimental model that is 502 
difficult to examine, yet one that promises to yield new insights into the biology of this 503 
structure.  504 
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Figure captions 690 
Table 1 691 
List of primers used for Real Time (TaqMan) PCR. 692 
 693 
Figure 1 694 
Histomorphological appearance of canine corpus luteum (CL) at days 5, 25, 45 and 65 post-695 
ovulation (p.o.; hematoxylin and eosin staining). (A,B) early luteal development at day 5 p.o. 696 
(corpus hemorrhagicum): extravascular erythrocytes (white arrowheads) can still be observed, 697 
distances between cells are relatively large, however, already at this stage well-established 698 
capillary networks indicate intense vascularization. (C,D) day 25 p.o., mature CL, reaching 699 
maximal steroidogenic capacity; fully developed lutein cells are polyhedral, tightly packed, 700 
with homogeneous cytoplasm (white arrows), while the luteal vascular bed is fully developed. 701 
(E,F) day 45 p.o., intercellular distances become larger, the density of capillaries decreases, 702 
the number of lutein cells also starts to decrease, larger lipid droplets begin to be visible in the 703 
cytoplasm of lutein cells (i.e., fatty degeneration becomes evident, black arrows), the number 704 
of connective tissue components increases. (G,H) day 65 p.o., marked signs of degeneration 705 
are visible in the form of large lipid vacuoles in the cytoplasm of lutein cells (black arrows), 706 
which become irregular in shape and size, chromatin condensation commences, pyknotic 707 
nuclei can be found, the content of connective tissue elements increases significantly. 708 
 709 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 23 
Figure 2 710 
Immunohistochemical detection of active caspase-3 in canine CL at the time of prepartum 711 
luteolysis, at low and high magnification (white arrows). The white arrowhead in the inset to 712 
the right hand picture shows a strongly degenerated lutein cell with large lipid vacuoles and 713 
pyknotic nucleus staining strongly for active caspase-3. 714 
 715 
Figure 3 716 
Expression of canine LH receptor (LHr) as determined by real time (TaqMan) PCR: (A) CL 717 
from non-pregnant cycles, days 5-65 p.o. (B) CL of pregnancy. Numerical data are presented 718 
as the mean ± standard deviation (SD). One-way ANOVA (P<0.05) was applied followed by 719 
the Tukey-Kramer multiple comparison test. Bars with different letters in Fig. 3B differ at 720 
p<0.05. 721 
 722 
Figure 4 723 
Time-dependent expression of canine 15-prostaglandin dehydrogenase (HPGD) as determined 724 
by real time (TaqMan) PCR in luteal samples from non-pregnant cycles, days 5-65 after 725 
ovulation. Numerical data are presented as the mean ± standard deviation (SD). One-way 726 
ANOVA (P<0.01) was applied followed by the Tukey-Kramer multiple comparison test. Bars 727 
with different letters differ at p<0.01. 728 
 729 
Figure 5 730 
Expression of vasoactive endothelial growth factor (VEGF) (A), VEGF-receptor 1 (VEGFR1) 731 
(B) and VEGF-receptor 2 (VEGFR2) (C) as determined by Real Time (TaqMan) PCR in 732 
luteal samples from dogs during mid-gestation and normal prepartum luteolysis (left hand 733 
panels), as well as during luteolysis induced with an antigestagen Aglepristone
®
 compared 734 
with the mid-gestation group (right hand panels). Numerical data are presented as the mean ± 735 
standard deviation (SD). For comparison between the mid-gestation and normal prepartum 736 
luteolysis, an unpaired t-test was performed. To evaluate changes in expression of target 737 
genes in response to the antigestagen, one-way ANOVA (P<0.01) was performed followed by 738 
Dunnet‟s multiple comparison test with the mid-gestation group used as a non-treated control 739 
(the respective results present the n-fold change in target gene expression compared to its 740 
mRNA-levels at mid gestation). Bars with different letters differ with P < 0.05 in Fig. 5A, and 741 
P<0.01 in Figs. 5B and C. 742 
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Figure 6 744 
Schematic presentation of hormonal mechanisms regulating luteal regression in non-pregnant 745 
dogs and prepartum luteolysis in pregnant ones, (modified after Kowalewski et al., [3]). 746 
 747 
Figure 7 748 
A schematic model illustrating proposed hormonal mechanisms regulating canine corpus 749 
luteum (CL) function. The early luteal phase is characterized by intense proliferation 750 
(indicated by increased expression of the Ki67 proliferation marker), high vascularization and 751 
strongly upregulated expression of steroidogenic acute regulatory protein (STAR) and 3-752 
hydroxysteroid-dehydorgenase (3HSD), which is reflected in rapidly increasing peripheral 753 
progesterone levels. During this time, the CL displays (more or less pronounced) 754 
refractoriness to gonadotrophic support, while the intraluteally-produced prostaglandins are 755 
among the important luteotrophic factors. This is reflected in the upregulated expression of 756 
cyclooxygenase 2 (COX2), PGE2-synthase (PGES) and prostaglandin transporter (PGT), and 757 
downregulated expression of 15-prostaglandin dehydrogenase (HPGD). Additionally, PGE2 758 
was proved to act as a luteotrophic factor in lutein cells from this early luteal phase. Both 759 
prolactin (PRL) and luteinizing hormone (LH) are luteotrophic factors, with PRL being the 760 
predominant one, especially during the second half of dioestrus when the canine CL is fully 761 
gonadotrophin-dependent. As the canine CL passes through its highest steroidogenic activity 762 
(about days 15-30 after ovulation), slow luteal regression sets in and the expression of STAR 763 
and 3HSD starts to decrease. At day 30 p.o. smooth endoplasmic reticulum (sER: an 764 
organelle in which microsomal enzymes like 3HSD, P450arom, 17HSD or inducible PGES 765 
isoform, i.e., mPGES, are being synthesized) reveals whirl-like structures and starts to 766 
degenerate, which is clearly visible by day 45 after ovulation when it encircles large lipid 767 
droplets - a further sign of ongoing fatty degeneration. Peripheral progesterone levels 768 
gradually decrease. Even though PRL and LH levels increase during this time, the expression 769 
of their respective receptors decreases, likely due to the ongoing degenerative process. 770 
Around day 60 of the CL life span, progesterone levels reach the so-called “lower threshold 771 
level” [3, 15, 36, 42, 59], which leads to alterations in the placental feto-maternal cross-talk, 772 
resulting in activation of the utero-placental prostaglandin system and prepartum PGF2 773 
output (resembling an effect that can be achieved after application of a progesterone receptor 774 
blocker = antiprogestin). 775 
Fig. 1 
Kowalewski 
A) Day 5 p.o. 
C) Day 25 p.o. 
E) Day 45 p.o. 
G) Day 65 p.o. 
B) Day 5 p.o. 
D) Day 25 p.o. 
H) Day 65 p.o. 
50µm 
F) Day 45 p.o. 
50µm 
50µm 
50µm 25µm  
25µm  
25µm  
25µm  
Figure 1
Kowalewski et al. 
Prepartum luteolysis, active caspase-3 
Fig. 2 
Isotype control 
50µm 50µm  25µm  
Kowalewski 
Figure 2
0 
2 
4 
6 
8 
10 
12 
14 
16 
d. 8-12 Grav d. 17-25 Grav d. 30-45 Grav Ad Term 
0 
5 
10 
15 
20 
25 
T5 d15 d25 d35 d45 d65 
Fig. 3 
A) Non-pregnant 
B) Pregnant 
d5             d15           d25            d35           d45            d65   
       Pre-                   Post-                   Mid-                  Prepartum   
       implantation      implantation        gestation           luteolysis 
Fo
ld
 c
ha
ng
e  
in
 lu
te
al
 L
H
R
 m
R
N
A 
le
ve
ls 
Fo
ld
 c
ha
ng
e  
in
 lu
te
al
 L
H
R
 m
R
N
A 
le
ve
ls 
d5 vs. d15 P<0.001 
d5 vs. d25 P<0.01 
d5 vs. d45 P<0.05 
d15 vs. d35 P<0.05 
Kowalewski 
a 
b 
b,c 
a,c 
b,c 
a,b 
a 
a,b 
b 
a,b 
Figure 3
Fo
ld
 c
ha
ng
e  
in
 lu
te
al
 H
P
G
D
 m
R
N
A 
le
ve
ls 
Fig. 4 
0 
10 
20 
30 
40 
50 
60 
70 
1 2 3 4 5 6        5               15              25             35              45              65  
a
a,b 
b 
b 
b b 
Kowalewski 
Figure 4
Fig. 5 
A) Fold change in VEGF164 mRNA levels 
0 
1 
2 
3 
4 
5 
6 
d. 30-45 Grav Prepartal luteolysis 
0 
1 
2 
3 
4 
5 
6 
d. 30-45 Grav 24h after 2nd 
Alizine treat. 
72h after 2nd 
Alizine treat. 
     24h        72h   
     After 2nd Aglepristone treatment 
   Mid-      
   gestation  
   Mid-      
   gestation  
    Prepartum      
    luteolysis 
P>0.05 
B) Fold change in VEGFR1 mRNA levels 
P>0.05 
0 
20 
40 
60 
80 
100 
120 
   Mid-      
   gestation  
    Prepartum   
    luteolysis 
0 
20 
40 
60 
80 
100 
120 
     24h          72h   
     After 2nd Aglepristone treatment  
a 
a,b 
b 
C) Fold change in VEGFR2 mRNA levels 
0 
2 
4 
6 
8 
10 
12 
   Mid-      
   gestation  
    Prepartum   
    luteolysis 
P>0.05 
0 
2 
4 
6 
8 
10 
12 
     24h          72h   
     After 2nd Aglepristone treatment  
a a,b 
b 
a a,b 
b 
   Mid-      
   gestation  
   Mid-      
   gestation  
Kowalewski 
Figure 5
Figure 6
vasculariza*on	  
Figure 7
Primer	   Accession	  
numbers	  
Primer	  sequence	   Product	  
	  length	  
(bp)	  
LHR-­‐for	   AF389885	  	   5’-­‐TCA	  TCA	  TTT	  GTG	  CTT	  GCT	  ACA	  TTA	  AA-­‐3’	  	   98	  
LHR-­‐rev	   5’-­‐CGC	  CAT	  TTT	  CTT	  AGC	  AAT	  CTT	  TG	  -­‐3’	  	  
LHR-­‐Taq	  Man	  Probe	   5’-­‐TGC	  AGT	  TCA	  AAA	  TCC	  AGA	  GCT	  GAT	  GGC	  -­‐3’	  	  
HPGD-­‐for	   NM_001284477	   5’-­‐GGC	  AGC	  GAA	  TCT	  CAT	  GAA	  CAG-­‐3’	  	   93	  
HPGD-­‐rev	   5’-­‐TCT	  TCT	  TTC	  TCA	  ATG	  GAT	  TCA	  AGG	  A-­‐3’	  	  
HPGD-­‐Taq	  Man	  Probe	   5’-­‐TGA	  ATG	  CCA	  TTT	  GCC	  CAG	  GCT	  TTG	  T-­‐3’	  	  
VEGF164-­‐for	   NM_001003175	  	   5’-­‐GTG	  CCC	  ACT	  GAG	  GAG	  TTC	  AAC-­‐3’	  	   72	  
VEGF164-­‐rev	   5’-­‐CCC	  TAT	  GTG	  CTG	  GCC	  TTG	  AT-­‐3’	  
VEGF164-­‐Taq	  Man	  Probe	   5’-­‐CAC	  CAT	  GCA	  GAT	  TAT	  GCG	  GAT	  CAA	  ACC-­‐3’	  	  
VEGFR1-­‐for	   AF262963	  	   5’-­‐TGC	  CTG	  AAA	  CAG	  TGA	  GAA	  AGG	  A-­‐3’	  	   81	  
VEGFR1-­‐rev	   5’-­‐TGC	  AGA	  ACT	  GTT	  TGC	  CAT	  TCC-­‐3’	  	  
VEGFR1-­‐Taq	  Man	  Probe	   5’-­‐AAA	  GGC	  TGA	  GCA	  TTA	  CTA	  AAT	  CTG	  CCT-­‐3’	  	  
VEGFR2-­‐for	   DQ269018	  /
NM_001048024	  
5’-­‐TGA	  CAT	  GGC	  CTC	  GGT	  CAT	  T-­‐3’	  	   75	  
VEGFR2-­‐rev	   5’-­‐TGT	  TGG	  TCG	  CTA	  ACA	  GAA	  GCA-­‐3’	  	  
VEGFR2-­‐Taq	  Man	  Probe	   5’-­‐CTA	  CGT	  TCA	  AGA	  TTA	  CAG	  GTC	  TCC	  ATT-­‐3’	  	  
GAPDH-­‐for	   AB028142	  	   5’-­‐GCT	  GCC	  AAA	  TAT	  GAC	  GAC	  ATC	  A-­‐3’	  	   75	  
GAPDH-­‐rev	   5’-­‐GTA	  GCC	  CAG	  GAT	  GCC	  TTT	  GAG-­‐3’	  	  
GAPDH-­‐Taq	  Man	  Probe	   5’-­‐TCC	  CTC	  CGA	  TGC	  CTG	  CTT	  CAC	  TAC	  CTT-­‐3’	  
18SrRNA-­‐for	   FJ797658	  	   5’-­‐GTC	  GCT	  CGC	  TCC	  TCT	  CCT	  ACT-­‐3’	  	   125	  
18SrRNA-­‐rev	   5’-­‐GGC	  TGA	  CCG	  GGT	  TGG	  TTT-­‐3’	  
18SrRNA-­‐Taq	  Man	  Probe	   5’-­‐ACA	  TGC	  CGA	  CGG	  GCG	  CTG	  AC-­‐3’	  	  
Cycophilin	  A	   Pre-­‐designed	  assay	  from	  Applied	  Biosystems,	  (Foster	  City,	  CA,	  USA)	  
Prod.	  No.	  Cf03986523-­‐	  gH	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